Search

everythinglearnresearchcommunity

for

Search:↓

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.